Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

Pharmaceutical packaging plays a crucial role in ensuring the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Primary packaging material, owing to the fact that it is in immediate contact with the drug / therapy formulation, is considered to be extremely important when it comes to preserving the stability, efficacy and safety of the packaged drug product. Further, given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative for drug / therapy packaging considerations to be re-evaluated, taking into consideration the evident shift from large batches of one remedy for everyone to smaller batches of more personalized therapeutic solutions. In addition to optimizing drug-packaging compatibility, stakeholders in the pharmaceutical packaging industry have also adopted a number of other flexible solutions to reduce the overall cost and expedite time to market.

The use of elastomeric materials, along with various types of coatings (such as FluoroTec® and Teflon® have emerged as a promising alternative to conventional, non-coated closures used for primary packaging containers, which were prone to leaching and shedding of particulate contaminants. The advantages of using elastomeric materials in manufacturing container closures are many, including low leaching potential, minimal chemical interaction with the pharmacological formulation, and the fact that they can be used to make waterproof and airtight closures. Moreover, such closures can also be manufactured in the ready-to-use (RTU) format, which saves a significant amount of time by eliminating the need for multiple steps in the overall fill / finish. Owing to the aforementioned benefits, the industry has witnessed an evident growth in preference for elastomeric container closures.

SCOPE OF THE REPORT
The ‘Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures’ report features a comprehensive study of the current scenario and future potential of the elastomeric, primary packaging closure market. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various types of primary packaging containers, such as cartridges, syringes and vials. In addition to other elements, the study includes:

A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if the closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product.

A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014), featuring an assessment of the packaging requirements of various container-closure systems based on parameters, such as year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure, and leading drug developers (in terms of number of drugs packaged using elastomeric closures).

An analysis of various developments / recent trends related to elastomeric packaging materials, offering insights on [A] partnerships and collaborations established within the industry, and [B] recent global conferences related to pharmaceutical packaging industry.

Elaborate profiles of key players in this domain (shortlisted on the basis of size of product portfolio), featuring a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of the executive team), financial information (if available), detailed description of proprietary elastomeric closures, recent developments, and an informed future outlook.

A case study on the role of robotics in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. It includes profiles of industry players offering such equipment for the aseptic processing of pharmaceutical products.

An elaborate discussion on emerging trends (such as focus on personalized therapies, shift towards more flexible packaging, upgrading packaging components to enhance drug product safety, and growing adoption of smart packaging solutions) that are likely to have an impact on the future adoption of elastomeric container-closure components in the pharmaceutical packaging industry. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.

An in-depth analysis to estimate the current and future demand for elastomeric closures across key primary packaging containers, including vials, syringes and cartridges, in different regions for the period 2019-2030. Input parameters considered for this analysis include current supply of different primary packaging components and their respective closures and the estimated the proportion of elastomeric closures that are likely to be supplied, which is indicative of the demand.

One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for elastomeric closures over the coming decade. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of such products, we have provided an informed estimate on the likely evolution of the market over the period 2019-2030. The report provides sales forecasts for the overall elastomeric closure market, wherein both the current and upcoming opportunity is segmented across [A] type of packaging container(s) (vials, syringes and cartridges), [B] type of closure(s) used (seal, stopper, cap, plunger, barrel, and needle shield), [C] sterilization status (pre-sterilized and unsterilized), and [D] key geographies (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):

Julien Maréchal (Business Development and Technology Director, Aseptic Technologies)
Malcolm Gilmore (Facilitator, BioPhorum Operations Group)
Marco Pederiva (Marketing and Sales Director, Lonstroff)
Konstantin Kazarian (Project Manager of Business Development, PYRAMID Laboratories)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY
The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews / surveys with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:
Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts’ views

While the focus has been on forecasting the market till 2030, the report also provides our independent view on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

CHAPTER OUTLINES
Chapter 2 provides an executive summary of the insights captured during our research. It offers a high-level view on the current state of the market of elastomeric closures and its likely evolution in the short-mid term and long term.

Chapter 3 provides an overview of conventional pharmaceutical packaging and the limitations associated with the currently used container-closure systems. The chapter also lays emphasis on innovation in the pharmaceutical packaging industry and the consequent growth of flexible fill / finish solutions. It features an elaborate discussion on the different considerations for choosing a suitable material for fabricating container-closure systems. Further, the chapter includes a detailed discussion on elastomeric materials, highlighting their properties, and applications across various industries. In addition, it provides an overview of regulatory guidelines associated with elastomeric container-closure systems. It elaborates on the various tests that are necessary to assess and control the quality of elastomeric closures. It concludes with a brief discussion on the advantages and limitations of elastomeric closures, highlighting the growing importance of coated elastomeric materials.

Chapter 4 provides a comprehensive review of the current market landscape of over 240 elastomeric closures. It includes a detailed analysis of the aforementioned products based on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product. It also provides details of the manufacturer companies, such as year of establishment, company size, and location of headquarters.

Chapter 5 features detailed profiles of key players (shortlisted on the basis of size of product portfolio) that are involved in fabricating and supplying elastomeric closures. Each company profile features a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of executive team), financial information (if available), detailed descriptions of proprietary elastomeric closures, recent developments and an informed future outlook.

Chapter 6 features packaging trends of over 230 drugs products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014). The chapter comprises of in-depth analyses, highlighting the packaging requirements of various container-closure systems based on several parameters, including year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure. Furthermore, we have highlighted the leading players in this domain, based on the number of approved drugs packaged using elastomeric closures in the given time period.

Chapter 7 features a detailed assessment of various developments / recent trends related to elastomeric packaging materials. The analysis presented in this chapter offers insights on [A] recent partnerships and collaborations that have been established in the last decade, featuring a comprehensive set of analyses, based on various parameters, such as the year of establishment and headquarters of each company, type of partnership, purpose of collaboration, and type of product, and [B] recent global conferences related to pharmaceutical packaging industry, featuring a set of analyses based on various parameters, such as year, location, and agenda of the conference.

Chapter 8 provides an overview of the current and future demand for elastomeric closures for key primary packaging containers, including vials, syringes and cartridges, in the contemporary market. In order to estimate the aforementioned demand, we considered the current supply of different primary packaging components and their respective closures and estimated the proportion of elastomeric closures that are likely to be supplied to the pharmaceutical industry. We also estimated the likely adoption of such products across geographical regions, over the period 2019-2030.

Chapter 9 presents a comprehensive market forecast analysis, highlighting the future potential of the market till 2030, based on multiple parameters, such as current demand for respective packaging components, likely adoption rates and the estimated price of components. It includes future sales projections of various closures of key packaging containers. We have segregated the current and upcoming opportunity on the basis of [A] type of packaging container(s) (vials, syringes and cartridges), [B] type of packaging closure(s) (seal, stopper, cap, plunger, barrel, and needle shield), [C] sterilization status (pre-sterilized and unsterilized), and [D] key geographies (North America, Europe and, Asia-Pacific and Rest of the World). It is worth mentioning that we adopted a bottom-up approach for this analysis, backing our claims with relevant datapoints and credible inputs from primary research.

Chapter 10 presents an elaborate case study on the role of robots in the pharmaceutical manufacturing and fill / finish process. It features a list of the various types of pharmaceutical robots, along with details on their respective manufacturer(s) and applications. Further, the chapter includes profiles of players that offer robotic machinery for pharmaceutical manufacturing and fill / finish operations, along with information on the key specifications of such products.

Chapter 11 discusses key trends in the overall pharmaceutical manufacturing industry. Specifically, it elaborates on the emerging focus on personalized therapies, shift towards more flexible packaging, development of modular facilities, upgrading packaging components to enhance drug product safety, increase in partnership activity, and growing adoption of smart packaging solutions, among others.

Chapter 12 is a collection of interview transcripts of discussions held with key stakeholders in this market. In this chapter, we have presented the details of interviews held with (in alphabetical order of company names) Julien Maréchal (Business Development and Technology Director, Aseptic Technologies), Malcolm Gilmore (Facilitator, BioPhorum Operations Group), Marco Pederiva (Marketing and Sales Director, Lonstroff), and Konstantin Kazarian (Project manager of Business Development Project Manager, PYRAMID Laboratories).

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in this report.

LIST OF COMPANIES AND ORGANIZATIONS

The following companies / institutes / government bodies and organizations have been mentioned in this report.

1. ABB
2. AbbVie
3. Abu Dhabi Polytechnic
4. ACADIA Pharmaceuticals
5. Accurate Elastomer Products
6. AcelRx Pharmaceuticals
7. Achaogen
8. Acme Vial and Glass
9. Acorda Therapeutics
10. Actelion Pharmaceuticals
11. Advanced Accelerator Applications
12. AdvantaPure
13. Aerie Pharmaceuticals
14. Afton Scientific
15. Agios Pharmaceuticals
16. AkaRx
17. Akcea Therapeutics
18. Alcon Laboratories
19. Alexion Pharmaceuticals
20. Alkermes
21. Allergan
22. Allergy Laboratories
23. Almirall
24. Amcor
25. Amgen
26. Amphastar Pharmaceuticals
27. Anacor Pharmaceuticals
28. Anhui Huafeng Pharmaceutical Rubber
29. Anhui Zhongma Rubber & Plastic Products
30. Antares Pharma
31. APG Europe
32. API Pharma
33. Aptar CSP Technologies
34. Aptar Pharma
35. Aquestive Therapeutics
36. ARaymond Life
37. Ariad Pharmaceuticals
38. ARLANXEO
39. Array BioPharma
40. Aseptic Technologies
41. Assem-Pak
42. Astellas Pharma
43. AstraZeneca
44. Automated Systems of Tacoma (AST)
45. Balda Group (part of Stevanato Group)
46. Bausch & Lomb
47. Bausch Health
48. Bayer
49. Becton Dickinson
50. Berry Global
51. Bespak
52. Bharat Rubber Works
53. BioCryst Pharmaceuticals
54. Biogen
55. BioMarin Pharmaceutical
56. BioPhorum Operations Group
57. Black Frame Advisors
58. BloodWorks Northwest
59. Blue Earth
60. Boehringer Ingelheim
61. Bosch Packaging Technology
62. Bracco Diagnostics
63. Bright Indotech
64. Bristol-Myers Squibb (BMS)
65. BV Holdings
66. C Otto Gehrckens
67. Caps and Seals
68. Catalyst Pharmaceuticals
69. Celgene
70. Celltrion
71. Chelsea Therapeutics
72. Chemo Research
73. Chiesi USA
74. Ciron Drugs
75. Cixi Lixin Rubber
76. Cleveland Cord Blood Center
77. Clovis Oncology
78. Cole-Parmer
79. Columbia Engineered Rubber
80. Corning
81. Cosmo Pharmaceuticals
82. CSPC Pharmaceutical Group
83. Cubist Pharmaceuticals
84. Daiichi Sankyo
85. Daikyo Seiko
86. Danyang Jincheng Medical Rubber & Plastics
87. Dara Pharmaceutical Packaging
88. Datwyler Sealing Solutions
89. Dayou Trading
90. Debiotech
91. DENSO
92. Dow Corning
93. DowDuPont Specialty Products (DuPont) Division
94. DSM Hydrocolloids
95. Duke University School of Medicine
96. Duran Group
97. Durata Therapeutics
98. DWK Life Sciences
99. Eastman Chemical
100. Eisai
101. Eli Lilly
102. Elusys Therapeutics
103. EMA Pharmaceuticals
104. EMD Serono
105. Enable Injections
106. ExxonMobil Chemical
107. EyePoint Pharmaceuticals
108. FANUC America
109. Fedegari Group
110. Ferrer
111. Fibrocell Technologies
112. Fresenius Kabi
113. GCL Pharma
114. GE Healthcare Life Sciences
115. Genentech
116. German Institute of Rubber Technology (DIK)
117. Gerresheimer
118. Gilead Sciences
119. GlaxoSmithKline
120. Greenwich Biosciences
121. H K Zion Industry
122. HealthPrize Technologies
123. Hebei First Rubber Medical Technology
124. Helsinn Healthcare
125. Henan Zhengzhou Songshan Enterprise Group
126. Hubei Huaqiang High-Tech
127. Hunan Runfuture Pharmatech
128. Industria Macchine Automatiche (IMA)
129. Infinity Pharmaceuticals
130. Insmed
131. Insulet
132. Intercept Pharmaceuticals
133. Ionis Pharmaceuticals
134. IPM Technologies
135. Ironwood Pharmaceuticals
136. ITF Pharma
137. Jain Rubbers
138. Jamnadas Industries
139. Janssen
140. Jazz Pharmaceuticals
141. Jiangsu Best New Medical Material
142. Jiangsu Hualan New Pharmaceutical Material
143. Jiangyin Aisun Import & Export
144. Jiangyin Chengfeng Rubber and Plastic
145. Jiangyin Hongmeng Rubber Plastic Product
146. Jiangyin Tejie Rubber & Plastic
147. Jiangyin Yonghong Rubber
148. Jinan Youlyy Industrial
149. JOTOP GLASS
150. KAI Pharmaceuticals
151. Kali Care
152. Kawasaki Heavy Industries
153. Kimble Chase
154. Kite Pharma
155. Kraton
156. KUKA
157. Kwality Pharma Rubber Industries
158. KWK Kremsmünster
159. Kyoraku
160. KYTHERA Biopharmaceuticals
161. La Jolla Pharmaceutical Company
162. Lanxess
163. Leadiant Biosciences
164. Leibniz Association
165. Lexicon Pharmaceuticals
166. LifeSouth Community Blood Centers
167. Lonstroff
168. Loxo Oncology
169. Lupin
170. Malaysian Rubber Board
171. Marchesini Group
172. Massman Automation Designs
173. Mayne Pharma
174. Medicines Development for Global Health
175. Megaplast
176. Melinta Therapeutics
177. Merck
178. Millennium Pharmaceuticals
179. Millipore Sigma
180. Mitsubishi Tanabe Pharma
181. MJS Packaging
182. Momentive
183. Motiba Silicone
184. Mylan
185. Naniwa Rubber
186. National University of Ireland, Galway
187. Neelam Global
188. Neurocrine Biosciences
189. Neutral Glass and Allied Industries
190. New York Blood Center
191. NextPharma Technologies
192. Ningbo Xingya Rubber & Plastic
193. Ningbo Zhengli Pharmaceutical Packing
194. Nipro PharmaPackaging
195. Noble International
196. Nordson EFD
197. Novartis
198. Novimmune
199. Novio
200. Novo Nordisk
201. NPS Pharmaceuticals
202. Ocular Therapeutics
203. Ohio State University
204. Ompi (part of Stevanato Group)
205. OMRON Industrial Automation
206. Organogenesis
207. Organon International
208. Ortho Dermatologics
209. Otsuka Pharmaceutical
210. Ott
211. Pack Source
212. Paladin Labs
213. Pall Biotech
214. Pall Life Sciences
215. Paratek Pharmaceuticals
216. Pfizer
217. PharMediPack Direkt
218. Piramal Imaging
219. Plas-Tech Engineering
220. PolyOne
221. Polytec Industries
222. Portola Pharmaceuticals
223. Prince Rubber & Plastics
224. Prince Sterilization Services
225. Propeller Health
226. Prysmian Group
227. PTC Therapeutics
228. Puma Biotechnology
229. Puyang Lumeng Glass Product
230. PYRAMID Laboratories
231. Qindao Huaren Medical
232. Qure Medical
233. Radius Health
234. RAUMEDIC
235. Regeneron Pharmaceuticals
236. Relypsa
237. Rempex Pharmaceuticals
238. Retrophin
239. Rigel Pharmaceuticals
240. Rizhao Donggang Mtntai Industry and Trade
241. Roche
242. RubberMill
243. Sagar Rubber Products
244. Samsung Medical Rubber
245. Sanofi
246. Sanofi Genzyme
247. Sarepta Therapeutics
248. SCHOTT
249. SCHOTT-KAISHA
250. Seiko Epson
251. Servier
252. Shady Pack
253. Shandong Pharmaceutical Glass
254. Sheng Zou Rubber & Plastics
255. Shenzhen Fushiyuan Rubber and Plastic Factory
256. Shionogi
257. Shire Pharmaceuticals
258. Shreenidhi Rubber
259. SHRIJI Rubber Industries
260. Shrinath Products (a division of Elmer Products)
261. Shyam Well Pack Industries
262. SIGA Technologies
263. SIGMA Plastic Services
264. SKAN
265. Sonata Rubber
266. Spark Therapeutics
267. Spectrum Pharmaceuticals
268. Splendid Industry
269. Sprout Pharmaceuticals
270. SSM Health Cardinal Glennon Children's Hospital
271. Staubli
272. Stemline Therapeutics
273. Steriline
274. Stock Cap
275. Strongbridge Biopharma
276. Sumitomo Rubber Industries
277. Sun Pharmaceutical Industries
278. SureCare
279. SVM Automatik
280. Synergy Pharmaceuticals
281. Taizhou Kanglong Pharmaceutical Packing
282. Taiho Oncology
283. TaiMed Biologics
284. Taiwan Ta Sheh Heng Yi Enterprise Group
285. Takeda Pharmaceuticals
286. Tekpak
287. TESARO
288. Tetraphase Pharmaceuticals
289. Teva Pharmaceutical Industries
290. Teva Respiratory (part of Teva Pharmaceutical Industries)
291. The Medicines Company
292. The Plasticoid Company
293. TherapeuticsMD
294. Theravance Biopharma
295. Tip-Top
296. Tohoku University
297. Triveni Polymers
298. Tyndall National Institute
299. UD Pharma Rubber Products
300. Ultragenyx Pharmaceutical
301. Union Chimique Belge
302. United Scientific Supplies
303. United Therapeutics
304. Universal Medicap
305. Universal Robots
306. University of Colorado Cord Blood Bank
307. Urologix
308. US WorldMeds
309. Valeant Pharmaceuticals
310. Vanda Pharmaceuticals
311. Vanrx Pharmasystems
312. Verastem Oncology
313. Vericel
314. Vertex Pharmaceuticals
315. Verux
316. Vighnesh Rubbers
317. Viscon Rubber
318. VitaMed
319. Vital Parts
320. VWR (a part of Avantor)
321. Weidmann Medical Technology
322. Wellstat Therapeutics
323. West Pharmaceutical Services
324. Wheaton Industries
325. Wyeth
326. Xiamen Petrel Rubber & Plastic Products
327. Yangjiang Jinbi Rubber Products
328. Yangzhong Wealth Metal
329. Yantai Xinhui Packing
330. Yaskawa Electric
331. Yichang Huaqiang Trade
332. Zhengzhou Aoxiang Pharmaceutical Packing
333. Zibo Dongda Medical Rubber


1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Types of Pharmaceutical Packaging
3.2.2. Innovation in Pharmaceutical Packaging
3.2.3. Traditional Aseptic Pharmaceutical Filling Operations
3.2.4. Limitations of Traditional Primary Packaging
3.3. Role of Containers-Closures Systems in Pharmaceutical Packaging
3.4. Types of Closures Used in Pharmaceutical Packaging
3.4.1. Closures for Prefilled Syringes / Syringes
3.4.2. Closures for Vials
3.4.3. Closures for Cartridges
3.5. Key Considerations for Choosing Materials for Fabricating Closures
3.6. Elastomeric Packaging Materials
3.6.1. Key Properties of Elastomeric Packaging Materials
3.6.2. Popular Types of Elastomeric Packaging Materials
3.6.3. Regulatory Guidelines for Elastomeric Closures
3.6.4. Manufacturing Process for Elastomeric Closures
3.6.5. Quality Assessment Tests for Elastomeric Closures
3.6.6. Advantages and Limitations of Elastomeric Packaging Materials
3.7. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Elastomeric Closures for Parenteral Containers: List of Products
4.2.1. Analysis by Type of Closure
4.2.1.1. Analysis by Type of Closure and Headquarters of Manufacturer
4.2.1.2. Analysis by Type of Closure and Size of Player
4.2.2. Analysis by Type of Container
4.2.3. Analysis by Type of Elastomeric Material
4.2.4. Analysis by Drug Class
4.2.5. Analysis by Sterilization Status
4.2.6. Analysis by Sterilization Technique
4.2.7. Analysis by Type of Coating
4.3. Elastomeric Closures for Parenteral Containers: List of Manufacturers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Target Market
4.3.5. Analysis by Scale of Production
4.3.6. Leading Manufacturers: Analysis by Number of Products
4.3.7. Manufacturer Landscape: Analysis by Company Size and Location of Headquarters
4.4. Elastomeric Closures for Parenteral Containers: Recent Initiatives of Players
4.5. Concluding Remarks
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Key Players Based in North America
5.2.1. Aptar Pharma (a Part of AptarGroup)
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Product Portfolio
5.2.1.4. Recent Developments and Future Outlook
5.2.2. DWK Life Sciences
5.2.2.1. Company Overview
5.2.2.2. Product Portfolio
5.2.2.3. Recent Developments and Future Outlook
5.2.3. West Pharmaceutical Services
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Product Portfolio
5.2.3.4. Recent Developments and Future Outlook
5.3. Key Players Based in Europe
5.3.1. Datwyler Sealing Solutions (a Part of Datwyler Group)
5.3.1.1. Company Overview
5.3.1.2. Financial Information
5.3.1.3. Product Portfolio
5.3.1.4 Recent Developments and Future Outlook
5.3.2. Lonstroff (a Part of Sumitomo Rubber Industries)
5.3.2.1. Company Overview
5.3.2.2. Financial Information
5.3.2.2. Product Portfolio
5.3.2.3. Recent Developments and Future Outlook
5.3.3. Ompi (a Part of Stevanato Group)
5.3.3.1. Company Overview
5.3.3.2. Product Portfolio
5.3.3.3. Recent Developments and Future Outlook
5.4. Key Players Based in Asia-Pacific
5.4.1 Daikyo Seiko
5.4.1.1. Company Overview
5.4.1.2. Product Portfolio
5.4.1.3. Recent Developments and Future Outlook
5.4.2. Hebei First Rubber Medical Technology (a Part of DESHENG Group)
5.4.2.1. Company Overview
5.4.2.2. Product Portfolio
5.4.2.3. Recent Developments and Future Outlook
5.4.3. Jiangsu Hualan New Pharmaceutical Material
5.4.3.1. Company Overview
5.4.3.2. Product Portfolio
5.4.3.3. Recent Developments and Future Outlook
6. PACKAGING TRENDS ANALYSIS FOR RECENTLY APPROVED DRUGS
6.1. Chapter Overview
6.2. List of Approved Drugs (2014-2018)
6.2.1. Analysis by Year of Approval
6.2.2. Analysis by Type of Molecule
6.2.3. Analysis by Type of Biologic
6.2.4. Analysis by Holding Temperature Range
6.2.5. Analysis by Type of Container
6.2.6. Analysis by Type of Container and Year of Approval
6.2.7. Analysis by Type of Container and Type of Molecule
6.2.8. Analysis by Type of Container and Dosage Form
6.2.9. Analysis by Type of Container and Route of Administration
6.2.10. Analysis by Type of Container and Holding Temperature Range
6.2.11. Popular Type of Material Used for Containers
6.2.12. Analysis by Type of Closure
6.2.13. Analysis by Type of Closure and Year of Approval
6.2.14. Analysis by Type of Closure and Type of Molecule
6.2.15. Analysis by Type of Closure and Dosage Form
6.2.16. Analysis by Type of Closure and Route of Administration
6.2.17. Analysis by Type of Closure and Holding Temperature Range
6.2.18. Popular Type of Material Used for Closures
6.2.19. Analysis by Type of Elastomeric Material Used for Closures and Dosage Form
6.2.20. Analysis by Type of Elastomeric Material Used for Closures and Route of Administration
6.2.21. Analysis by Type of Elastomeric Material Used for Closures and Holding Temperature Range
6.2.22. Analysis by Type of Elastomeric Material Used for Closures
6.2.23. Most Active Players: Analysis by Number of Drugs Packaged Using Elastomeric Closures
6.2.24. Concluding Remarks
7. RECENT DEVELOPMENTS
7.1. Chapter Overview
7.2. Pharmaceutical Packaging Industry: Partnership Activity
7.2.1. Partnership Models
7.2.2. List of Partnerships and Collaborations
7.2.2.1. Analysis by Year of Partnership
7.2.2.2. Analysis by Type of Partnership
7.2.2.3. Analysis by Focus Area
7.2.2.4. Most Active Players: Analysis by Number of Partnerships
7.3. Elastomeric Container Closures in Pharmaceutical Packaging Industry: Recent Expansions
7.4. Pharmaceutical Packaging Industry: Recent Conferences
7.4.1. List of Recent Conferences
7.4.1.1. Analysis by Year of Occurrence
7.4.1.2. Analysis by Geography
7.4.2. Elastomeric Container Closures: List of Recent Conferences
7.4.2.1. Analysis by Focus Area / Agenda
7.4.3. Geographical Mapping of Conferences
7.5. Concluding Remarks
8. DEMAND ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Global Demand for Elastomeric Closures, 2019-2030
8.3.1. Analysis by Type of Primary Container
8.3.1.1. Global Demand for Elastomeric Closures for Vials
8.3.1.2. Global Demand for Elastomeric Closures for Syringes
8.3.1.3. Global Demand for Elastomeric Closures for Cartridges
8.3.2. Analysis by Type of Closure
8.3.2.1. Global Demand for Elastomeric Seals
8.3.2.2. Global Demand for Elastomeric Stoppers
8.3.2.3. Global Demand for Elastomeric Caps
8.3.2.4. Global Demand for Elastomeric Plungers
8.3.2.5. Global Demand for Elastomeric Barrels
8.3.2.6. Global Demand for Elastomeric Needle Shields
8.3.3. Analysis by Sterilization Status
8.3.3.1. Global Demand for Pre-Sterilized Elastomeric Closures
8.3.3.1.1. Global Demand for Pre-Sterilized Elastomeric Seals
8.3.3.1.2. Global Demand for Pre-Sterilized Elastomeric Stoppers
8.3.3.1.3. Global Demand for Pre-Sterilized Elastomeric Caps
8.3.3.1.4. Global Demand for Pre-Sterilized Elastomeric Plungers
8.3.3.1.5. Global Demand for Pre-Sterilized Elastomeric Barrels
8.3.3.1.6. Global Demand for Pre-Sterilized Elastomeric Needle Shields
8.3.3.2. Global Demand for Unsterilized Elastomeric Closures
8.3.3.2.1. Global Demand for Unsterilized Elastomeric Seals
8.3.3.2.2. Global Demand for Unsterilized Elastomeric Stoppers
8.3.3.2.3. Global Demand for Unsterilized Elastomeric Caps
8.3.3.2.4. Global Demand for Unsterilized Elastomeric Plungers
8.3.3.2.5. Global Demand for Unsterilized Elastomeric Barrels
8.3.3.2.6. Global Demand for Unsterilized Elastomeric Needle Shields
8.3.4. Analysis by Geography
8.3.4.1. Demand for Elastomeric Closures in North America
8.3.4.1.1. Demand for Elastomeric Seals in North America
8.3.4.1.2. Demand for Elastomeric Stoppers in North America
8.3.4.1.3. Demand for Elastomeric Caps in North America
8.3.4.1.4. Demand for Elastomeric Plungers in North America
8.3.4.1.5. Demand for Elastomeric Barrels in North America
8.3.4.1.6. Demand for Elastomeric Needle Shields in North America
8.3.4.2. Demand for Elastomeric Closures in Europe
8.3.4.2.1. Demand for Elastomeric Seals in Europe
8.3.4.2.2. Demand for Elastomeric Stoppers in Europe
8.3.4.2.3. Demand for Elastomeric Caps in Europe
8.3.4.2.4. Demand for Elastomeric Plungers in Europe
8.3.4.2.5. Demand for Elastomeric Barrels in Europe
8.3.4.2.6. Demand for Elastomeric Needle Shields in Europe
8.3.4.3. Demand for Elastomeric Closures in Asia-Pacific
8.3.4.3.1. Demand for Elastomeric Seals in Asia-Pacific
8.3.4.3.2. Demand for Elastomeric Stoppers in Asia-Pacific
8.3.4.3.3. Demand for Elastomeric Caps in Asia-Pacific
8.3.4.3.4. Demand for Elastomeric Plungers in Asia-Pacific
8.3.4.3.5. Demand for Elastomeric Barrels in Asia-Pacific
8.3.4.3.6. Demand for Elastomeric Needle Shields in Asia-Pacific
8.3.4.4. Demand for Elastomeric Closures in Rest of the World
8.3.4.4.1. Demand for Elastomeric Seals in Rest of the World
8.3.4.4.2. Demand for Elastomeric Stoppers in Rest of the World
8.3.4.4.3. Demand for Elastomeric Caps in Rest of the World
8.3.4.4.4. Demand for Elastomeric Plungers in Rest of the World
8.3.4.4.5. Demand for Elastomeric Barrels in Rest of the World
8.3.4.4.6. Demand for Elastomeric Needle Shields in Rest of the World
8.4. Concluding Remarks
9. MARKET FORECAST
9.1. Chapter Overview
9.2. Forecast Methodology and Key Assumptions
9.3. Global Elastomeric Closures Market, 2019-2030
9.3.1. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container
9.3.1.1. Global Elastomeric Closures Market for Vials, 2019-2030
9.3.1.2. Global Elastomeric Closures Market for Syringes, 2019-2030
9.3.1.3. Global Elastomeric Closures Market for Cartridges, 2019-2030
9.3.2. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure
9.3.2.1. Global Elastomeric Closures Market for Seals, 2019-2030
9.3.2.2. Global Elastomeric Closures Market for Stoppers, 2019-2030
9.3.2.3. Global Elastomeric Closures Market for Caps, 2019-2030
9.3.2.4. Global Elastomeric Closures Market for Plungers, 2019-2030
9.3.2.5. Global Elastomeric Closures Market for Barrels, 2019-2030
9.3.2.6. Global Elastomeric Closures Market for Needle Shields, 2019-2030
9.3.3. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status
9.3.3.1. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030
9.3.3.1.1. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030
9.3.3.1.2. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030
9.3.3.1.3. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030
9.3.3.1.4. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030
9.3.3.1.5. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030
9.3.3.1.6. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030
9.3.3.2. Global Unsterilized Elastomeric Closures Market, 2019-2030
9.3.3.2.1. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030
9.3.3.2.2. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030
9.3.3.2.3. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030
9.3.3.2.4. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030
9.3.3.2.5. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030
9.3.3.2.6. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030
9.3.4. Global Elastomeric Closures Market, 2019-2030: Distribution by Geography
9.3.4.1. Elastomeric Closures Market in North America, 2019-2030
9.3.4.1.1. Elastomeric Closures Market for Seals in North America, 2019-2030
9.3.4.1.2. Elastomeric Closures Market for Stoppers in North America, 2019-2030
9.3.4.1.3. Elastomeric Closures Market for Caps in North America, 2019-2030
9.3.4.1.4. Elastomeric Closures Market for Plungers in North America, 2019-2030
9.3.4.1.5. Elastomeric Closures Market for Barrels in North America, 2019-2030
9.3.4.1.6. Elastomeric Closures Market for Needle Shields in North America, 2019-2030
9.3.4.2. Elastomeric Closures Market in Europe, 2019-2030
9.3.4.2.1. Elastomeric Closures Market for Seals in Europe, 2019-2030
9.3.4.2.2. Elastomeric Closures Market for Stoppers in Europe, 2019-2030
9.3.4.2.3. Elastomeric Closures Market for Caps in Europe, 2019-2030
9.3.4.2.4. Elastomeric Closures Market for Plungers in Europe, 2019-2030
9.3.4.2.5. Elastomeric Closures Market for Barrels in Europe, 2019-2030
9.3.4.2.6. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030
9.3.4.3. Elastomeric Closures Market in Asia-Pacific, 2019-2030
9.3.4.3.1. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030
9.3.4.3.2. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030
9.3.4.3.3. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030
9.3.4.3.4. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030
9.3.4.3.5. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030
9.3.4.3.6. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030
9.3.4.4. Elastomeric Closures Market in Rest of the World, 2019-2030
9.3.4.4.1. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030
9.3.4.4.2. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030
9.3.4.4.3. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030
9.3.4.4.4. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030
9.3.4.4.5. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030
9.3.4.4.6. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030
9.4. Concluding Remarks
10. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING
10.1. Chapter Overview
10.2. Role of Robots in the Pharmaceutical Industry
10.2.1. Key Considerations for Selecting a Robotic System
10.2.2. Advantages of Robotic Systems
10.2.3. Disadvantages of Robotic Systems
10.3. Companies Providing Robots for Pharmaceutical Industry
10.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
10.4.1. Aseptic Technologies
10.4.1.1. Crystal® L1 Robot Line
10.4.1.2. Crystal® SL1 Robot Line
10.4.2. AST
10.4.2.1. ASEPTiCell® Series
10.4.2.2. ASEPTiCell® VSM-25
10.4.3. Bosch Packaging Technology
10.4.3.1. ATO
10.4.4. Dara Pharmaceutical Packaging
10.4.4.1. SYX-E CARTRIDGE + RABS
10.4.5. Fedegari Group
10.4.5.1. Fedegari Isolator
10.4.6. IMA
10.4.6.1. INJECTA
10.4.6.2. STERI LIF3
10.4.7. Steriline
10.4.7.1. Nest Filling Line RNFM
10.4.8. Vanrx Pharmasystems
10.4.8.1. Microcell Vial Filler
10.4.8.2. SA25 Aseptic Filling Workcell
11. EMERGING TRENDS IN PHARMACEUTICAL PACKAGING
11.1. Chapter Overview
11.2. Shift Towards Self-Medication using Advanced Drug Delivery Devices
11.3. Focus on Developing Improved Packaging Components and Ongoing Efforts to Optimize Manufacturing Costs
11.4. Availability of Modular Facilities
11.5. Initiatives Focused on Automation of Fill / Finish Operations
11.6. Establishment of Business Relationships Focused on Designing Compatible Packaging Materials for Various Drug Products
11.7. Increasing Activity in Developing Regions
11.8. Growing Adoption of Smart Packaging Solutions
11.9. Concluding Remarks
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. Aseptic Technologies
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Julien Maréchal, Business Development and Technology Director
12.3. BioPhorum Operations Group
12.3.1. Company Snapshot
13.3.2. Interview Transcript: Malcolm Gilmore, Facilitator
12.4. Lonstroff
12.4.1. Company Snapshot
12.4.2. Interview Transcript: Marco Pederiva, Marketing and Sales Director
12.5. PYRAMID Laboratories
12.5.1. Company Snapshot
12.5.2. Interview Transcript: Konstantin Kazarian, Business Development Project Manager
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 3.1 Advantages of Pharmaceutical Packaging
Figure 3.2 Types of Pharmaceutical Packaging
Figure 3.3 Innovation in Pharmaceutical Packaging
Figure 3.4 Traditional Aseptic Pharmaceutical Filling
Figure 3.5 List of Various Primary Packaging Containers-Closures Systems
Figure 3.6 Applications of Elastomeric Materials in Various Industries
Figure 3.7 Key Properties of Elastomeric Materials
Figure 3.8 Comparison of Different Types of Packaging Materials
Figure 3.9 Elastomeric Closures: Manufacturing Process
Figure 3.10 Advantages and Limitations of Elastomeric Materials Used in Pharmaceutical Packaging Industry
Figure 4.1 Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
Figure 4.2 Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure and Headquarter of Manufacturer
Figure 4.3 Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure and Size of Player
Figure 4.4 Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
Figure 4.5 Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
Figure 4.6 Elastomeric Closures for Parenteral Containers: Distribution by Drug Class
Figure 4.7 Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
Figure 4.8 Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
Figure 4.9 Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
Figure 4.10 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
Figure 4.11 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
Figure 4.12 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
Figure 4.13 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Target Market
Figure 4.14 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
Figure 4.15 Leading Manufacturers: Distribution by Number of Products
Figure 4.16 Manufacturer Landscape: Distribution by Company Size and Location of Headquarters
Figure 4.17 Heat Map Analysis: Comparison of Coated Closures for Different Types of Containers
Figure 5.1 AptarGroup: Annual Revenues, 2013-Q3 2018 (USD Billion)
Figure 5.2 West Pharmaceutical Services: Annual Revenues, 2013-Q1 2019 (USD Billion)
Figure 5.3 Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
Figure 5.4 Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
Figure 5.5 Sumitomo Rubber Industries: Annual Revenues by Business Segments, 2018
Figure 6.1 Approved Drugs (2014-2018): Distribution by Year of Approval
Figure 6.2 Approved Drugs (2014-2018): Distribution by Type of Molecule
Figure 6.3 Approved Drugs (2014-2018): Distribution by Type of Biologic
Figure 6.4 Approved Drugs (2014-2018): Distribution by Holding Temperature Range
Figure 6.5 Approved Drugs (2014-2018): Distribution by Type of Container
Figure 6.6 Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
Figure 6.7 Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
Figure 6.8 Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
Figure 6.9 Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
Figure 6.10 Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
Figure 6.11 Approved Drugs (2014-2018): Popular Type of Material Used in Containers for Biologics
Figure 6.12 Approved Drugs (2014-2018): Popular Type of Material Used in Containers for Small Molecule
Figure 6.13 Approved Drugs (2014-2018): Distribution by Type of Closure
Figure 6.14 Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
Figure 6.15 Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
Figure 6.16 Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
Figure 6.17 Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
Figure 6.18 Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
Figure 6.19 Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
Figure 6.20 Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
Figure 6.21 Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
Figure 6.22 Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
Figure 6.23 Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
Figure 6.24 Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures
Figure 6.25 Most Active Players: Distribution by Number of Drugs Packaged using Elastomeric Closures
Figure 6.26 Approved Drugs (2014-2018), Grid Analysis: Distribution by Type of Container, Closure, Type of Material and Route of Administration
Figure 6.27 Approved Drugs (2014-2018), Bubble Analysis: Distribution by Type of Closure, Type of Elastomeric Material and Type of Molecule
Figure 7.1 Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Focus Area
Figure 7.4 Partnerships and Collaborations: Most Active Players
Figure 7.5 Global Conferences: Cumulative Year-Wise Trend, 2015-2019
Figure 7.6 Global Conferences: Distribution by Location
Figure 7.7 Global Conferences Related to Elastomeric Containers Closures: Key Focus Areas
Figure 7.8 Global Conferences: Geographical Mapping
Figure 8.1 Global Demand for Elastomeric Closures: Methodology and Key Assumptions
Figure 8.2 Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.3 Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
Figure 8.4 Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
Figure 8.5 Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
Figure 8.6 Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
Figure 8.7 Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
Figure 8.8 Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.9 Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.10 Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.11 Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.12 Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.13 Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.14 Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
Figure 8.15 Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.16 Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.17 Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.18 Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.19 Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.20 Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.21 Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.22 Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
Figure 8.23 Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
Figure 8.24 Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Figure 8.25 Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
Figure 8.26 Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Figure 8.27 Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Figure 8.28 Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Figure 8.29 Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
Figure 8.30 Demand for Elastomeric Closures in North America, 2019-2030 (Billion Units)
Figure 8.31 Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
Figure 8.32 Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
Figure 8.33 Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
Figure 8.34 Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
Figure 8.35 Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
Figure 8.36 Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
Figure 8.37 Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
Figure 8.38 Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
Figure 8.39 Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
Figure 8.40 Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
Figure 8.41 Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
Figure 8.42 Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
Figure 8.43 Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
Figure 8.44 Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.45 Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.46 Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.47 Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.48 Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.49 Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.50 Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
Figure 8.51 Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
Figure 8.52 Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
Figure 8.53 Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
Figure 8.54 Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
Figure 8.55 Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
Figure 8.56 Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
Figure 8.57 Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
Figure 9.1 Global Elastomeric Closures Market: Forecast Methodology and Key Assumptions
Figure 9.2 Global Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.3 Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
Figure 9.4 Global Elastomeric Closures Market for Vials, 2019-2030 (USD Billion)
Figure 9.5 Global Elastomeric Closures Market for Syringes, 2019-2030 (USD Billion)
Figure 9.6 Global Elastomeric Closures Market for Cartridges, 2019-2030 (USD Billion)
Figure 9.7 Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
Figure 9.8 Global Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.9 Global Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.10 Global Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.11 Global Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.12 Global Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.13 Global Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Million)
Figure 9.14 Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
Figure 9.15 Global Pre-Sterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.16 Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.17 Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
Figure 9.18 Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.19 Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.20 Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
Figure 9.21 Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Million)
Figure 9.22 Global Unsterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
Figure 9.23 Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
Figure 9.24 Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Million)
Figure 9.25 Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
Figure 9.26 Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
Figure 9.27 Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Million)
Figure 9.28 Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Million)
Figure 9.29 Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
Figure 9.30 Elastomeric Closures Market in North America, 2019-2030 (USD Billion)
Figure 9.31 Elastomeric Closures Market for Seals in North America, 2019-2030 (USD Million)
Figure 9.32 Elastomeric Closures Market for Stoppers in North America, 2019-2030 (USD Billion)
Figure 9.33 Elastomeric Closures Market for Caps in North America, 2019-2030 (USD Billion)
Figure 9.34 Elastomeric Closures Market for Plungers in North America, 2019-2030 (USD Million)
Figure 9.35 Elastomeric Closures Market for Barrels in North America, 2019-2030 (USD Million)
Figure 9.36 Elastomeric Closures Market for Needle Shields in North America, 2019-2030 (USD Million)
Figure 9.37 Elastomeric Closures Market in Europe, 2019-2030 (USD Billion)
Figure 9.38 Elastomeric Closures Market for Seals in Europe, 2019-2030 (USD Million)
Figure 9.39 Elastomeric Closures Market for Stoppers in Europe, 2019-2030 (USD Billion)
Figure 9.40 Elastomeric Closures Market for Caps in Europe, 2019-2030 (USD Million)
Figure 9.41 Elastomeric Closures Market for Plungers in Europe, 2019-2030 (USD Million)
Figure 9.42 Elastomeric Closures Market for Barrels in Europe, 2019-2030 (USD Million)
Figure 9.43 Elastomeric Closures Market for Needle Shields in Europe, 2019-2030 (USD Million)
Figure 9.44 Elastomeric Closures Market in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.45 Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030 (USD Million)
Figure 9.46 Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030 (USD Billion)
Figure 9.47 Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030 (USD Million)
Figure 9.48 Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030 (USD Million)
Figure 9.49 Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030 (USD Million)
Figure 9.50 Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030 (USD Million)
Figure 9.51 Elastomeric Closures Market in Rest of the World, 2019-2030 (USD Million)
Figure 9.52 Elastomeric Closures Market for Seals in Rest of the World, 2019-2030 (USD Million)
Figure 9.53 Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030 (USD Million)
Figure 9.54 Elastomeric Closures Market for Caps in Rest of the World, 2019-2030 (USD Million)
Figure 9.55 Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030 (USD Million)
Figure 9.56 Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030 (USD Million)
Figure 9.57 Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030 (USD Million)
Figure 9.58 Overall Elastomeric Closures Market: Conservative, Base and Optimistic Scenario, 2019, 2024 and 2030 (USD Billion)
Figure 10.1 Key Considerations to Select a Robot
Figure 10.2 Advantages of Robotic Systems in Pharmaceutical Operations
Figure 11.1 Emerging Trends Related to Pharmaceutical Packaging
Figure 11.2 Future Growth Opportunities Related to Elastomeric Closures 
LIST OF TABLES
Table 3.1 Key Components of Syringes
Table 3.2 Popular Types of Elastomeric Packaging Materials
Table 3.3 Popular Coatings / Surface Treatment Methods Used for Elastomeric Closures
Table 4.1 List of Elastomeric Closures for Parenteral Containers
Table 4.2 Elastomeric Closures for Parenteral Containers: Information on Type of Container
Table 4.3 Elastomeric Closures for Parenteral Containers: Information on Type of Elastomeric Material and Type of Drug Class
Table 4.4 Elastomeric Closures for Parenteral Containers: Information on Sterilization Status
Table 4.5 Elastomeric Closures for Parenteral Containers: Additional Information
Table 4.6 Elastomeric Closures for Parenteral Containers: Information on Manufacturers
Table 4.7 Elastomeric Closures for Parenteral Containers: Information on Scale of Operation of Manufacturers
Table 4.8 List of Ready-to-Use Containers-Closures Systems
Table 5.1 Elastomeric Container Closure Providers: List of Companies Profiled
Table 5.2 AptarGroup: Company Overview
Table 5.3 Aptar Pharma: Product Details
Table 5.4 AptarGroup: Recent Developments and Future Outlook
Table 5.5 DWK Life Sciences: Company Overview
Table 5.6 DWK Life Sciences: Product Details
Table 5.7 DWK Life Sciences: Recent Developments and Future Outlook
Table 5.8 West Pharmaceutical Services: Company Overview
Table 5.9 West Pharmaceutical Services: Product Details
Table 5.10 West Pharmaceutical Services: Recent Developments and Future Outlook
Table 5.11 Datwyler Sealing Solutions (a Part of Datwyler Group): Company Overview
Table 5.12 Datwyler Sealing Solutions (a Part of Datwyler Group): Product Details
Table 5.13 Datwyler Sealing Solutions (a Part of Datwyler Group): Recent Developments and Future Outlook
Table 5.14 Lonstroff: Company Overview
Table 5.15 Sumitomo Rubber Industries: Company Overview
Table 5.16 Lonstroff: Product Details
Table 5.17 Sumitomo Rubber Industries: Recent Developments and Future Outlook
Table 5.18 Ompi (a Part of Stevanato Group): Company Overview
Table 5.19 Ompi (a Part of Stevanato Group): Product Details
Table 5.20 Ompi (a Part of Stevanato Group): Recent Developments and Future Outlook
Table 5.21 Daikyo Seiko: Company Overview
Table 5.22 Daikyo Seiko: Product Details
Table 5.23 Daikyo Seiko: Recent Developments and Future Outlook
Table 5.24 Hebei First Rubber Medical Technology (a Part of DESHENG Group): Company Overview
Table 5.25 Hebei First Rubber Medical Technology (a Part of DESHENG Group): Product Details
Table 5.26 Jiangsu Hualan New Pharmaceutical Material: Company Overview
Table 5.27 Jiangsu Hualan New Pharmaceutical Material: Product Details
Table 6.1 List of Approved Drugs (2014-2018): Information on Dosage Form, Route of Administration and Holding Temperature Range
Table 6.2 List of Approved Drugs (2014-2018): Information on Type of Container and Container Material
Table 6.3 List of Approved Drugs (2014-2018): Information on Type of Closure and Closure Material
Table 7.1 List of Partnerships and Collaborations: Information on Year and Type, 2007-2019
Table 7.2 List of Partnerships and Collaborations: Information on Focus Area and Product Type, 2007-2019
Table 7.3 List of Recent Expansions, 2014-2018
Table 7.4 Pharmaceutical Packaging Industry: List of Conferences, 2013-2019
Table 7.5 Conferences Related to Elastomeric Containers Closures: Information of Focus Area / Agenda
Table 7.6 Conferences Related to Elastomeric Containers Closures: Information on Key Speakers
Table 9.1 Regional Variation in Prices of Elastomeric Closures
Table 10.1 Pharmaceutical Robotics Manufacturers
Table 10.2 Aseptic Technologies: Company Overview
Table 10.3 Aseptic Technologies: Key Specifications of Crystal® L1 Robot Line
Table 10.4 Aseptic Technologies: Key Specifications of Crystal® SL1 Robot Line
Table 10.5 AST: Company Overview
Table 10.6 AST: Key Specifications of ASEPTiCell® Series
Table 10.7 AST: Key Specifications of ASEPTiCell® VSM-25
Table 10.8 Bosch Packaging Technology: Company Overview
Table 10.9 Bosch Packaging Technology: Key Specifications of ATO
Table 10.10 Dara Pharmaceutical Packaging: Company Overview
Table 10.11 Dara Pharmaceutical Packaging: Key Specifications of SYX-E CARTRIDGE + RABS
Table 10.12 Fedegari Group: Company Overview
Table 10.13 Fedegari Group: Key Specifications of Fedegari Isolator
Table 10.14 IMA: Company Overview
Table 10.15 IMA: Key Specifications of INJECTA
Table 10.16 IMA: Key Specifications of STERI LIF3
Table 10.17 Steriline: Company Overview
Table 10.18 Steriline: Key Specifications of Nest Filling Line RNFM
Table 10.19 Vanrx Pharmasystems: Company Overview
Table 10.20 Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
Table 10.21 Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
Table 12.1 Aseptic Technologies: Company Snapshot
Table 12.2 BioPhorum Operations Group: Company Snapshot
Table 12.3 Lonstroff: Company Snapshot
Table 12.4 PYRAMID Laboratories: Company Snapshot
Table 13.1 Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
Table 13.2 Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure and Headquarter of Manufacturer
Table 13.3 Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure and Size of Player
Table 13.4 Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
Table 13.5 Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
Table 13.6 Elastomeric Closures for Parenteral Containers: Distribution by Type of Drug Class
Table 13.7 Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
Table 13.8 Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
Table 13.9 Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
Table 13.10 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
Table 13.11 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
Table 13.12 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
Table 13.13 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Target Market
Table 13.14 Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
Table 13.15 Leading Manufacturers: Distribution by Number of Products
Table 13.16 Manufacturer Landscape: Distribution by Company Size and Location of Headquarters
Table 13.17 AptarGroup: Annual Revenues, 2013-9M 2018 (USD Billion)
Table 13.18 West Pharmaceutical Services: Annual Revenues, 2013-Q1 2019 (USD Billion)
Table 13.19 Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
Table 13.20 Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
Table 13.21 Sumitomo Rubber Industries: Annual Revenues by Business Segment, 2018
Table 13.22 Approved Drugs (2014-2018): Distribution by Year of Approval
Table 13.23 Approved Drugs (2014-2018): Distribution by Type of Molecule
Table 13.24 Approved Drugs (2014-2018): Distribution by Type of Biologic
Table 13.25 Approved Drugs (2014-2018): Distribution by Holding Temperature Range
Table 13.26 Approved Drugs (2014-2018): Distribution by Type of Container
Table 13.27 Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
Table 13.28 Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
Table 13.29 Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
Table 13.30 Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
Table 13.31 Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
Table 13.32 Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Biologics
Table 13.33 Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Small Molecule
Table 13.34 Approved Drugs (2014-2018): Distribution by Type of Closure
Table 13.35 Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
Table 13.36 Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
Table 13.37 Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
Table 13.38 Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
Table 13.39 Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
Table 13.40 Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
Table 13.41 Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
Table 13.42 Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
Table 13.43 Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
Table 13.44 Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
Table 13.45 Approved Drugs (2014-2018): Distribution by Types of Elastomeric Material Used for Closures
Table 13.46 Most Active Players: Distribution by Number of Drugs Packaged Using Elastomeric Closures
Table 13.47 Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
Table 13.48 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.49 Partnerships and Collaborations: Distribution by Focus Area
Table 13.50 Partnerships and Collaborations: Most Active Players
Table 13.51 Global Conferences: Cumulative Year-Wise Trend, 2015-2019
Table 13.52 Global Conferences: Distribution by Location
Table 13.53 Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.54 Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
Table 13.55 Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
Table 13.56 Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
Table 13.57 Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
Table 13.58 Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
Table 13.59 Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.60 Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.61 Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.62 Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.63 Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.64 Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.65 Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
Table 13.66 Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.67 Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.68 Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.69 Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.70 Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.71 Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.72 Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.73 Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
Table 13.74 Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
Table 13.75 Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
Table 13.76 Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
Table 13.77 Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
Table 13.78 Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
Table 13.79 Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
Table 13.80 Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
Table 13.81 Demand for Elastomeric Closures in North America, 2019-2030 (Billion Units)
Table 13.82 Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
Table 13.83 Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
Table 13.84 Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
Table 13.85 Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
Table 13.86 Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
Table 13.87 Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
Table 13.88 Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
Table 13.89 Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
Table 13.90 Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
Table 13.91 Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
Table 13.92 Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
Table 13.93 Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
Table 13.94 Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
Table 13.95 Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.96 Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.97 Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.98 Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.99 Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.100 Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.101 Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
Table 13.102 Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
Table 13.103 Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
Table 13.104 Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
Table 13.105 Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
Table 13.106 Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
Table 13.107 Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
Table 13.108 Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
Table 13.109 Global Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.110 Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
Table 13.111 Global Elastomeric Closures Market for Vials, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.112 Global Elastomeric Closures Market for Syringes, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.113 Global Elastomeric Closures Market for Cartridges, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.114 Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
Table 13.115 Global Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.116 Global Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.117 Global Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.118 Global Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.119 Global Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.120 Global Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.121 Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
Table 13.122 Global Pre-Sterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.123 Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.124 Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.125 Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.126 Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.127 Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.128 Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.129 Global Unsterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.130 Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.131 Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.132 Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.133 Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.134 Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.135 Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.136 Global Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
Table 13.137 Elastomeric Closures Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.138 Elastomeric Closures Market for Seals in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.139 Elastomeric Closures Market for Stoppers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.140 Elastomeric Closures Market for Caps in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.141 Elastomeric Closures Market for Plungers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.142 Elastomeric Closures Market for Barrels in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.143 Elastomeric Closures Market for Needle Shields in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.144 Elastomeric Closures Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.145 Elastomeric Closures Market for Seals in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.146 Elastomeric Closures Market for Stoppers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.147 Elastomeric Closures Market for Caps in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.148 Elastomeric Closures Market for Plungers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.149 Elastomeric Closures Market for Barrels in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.150 Elastomeric Closures Market for Needle Shields in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.151 Elastomeric Closures Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.152 Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.153 Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
Table 13.154 Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.155 Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.156 Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.157 Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.158 Elastomeric Closures Market in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.159 Elastomeric Closures Market for Seals in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.160 Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.161 Elastomeric Closures Market for Caps in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenario (USD Million)
Table 13.162 Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.163 Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.164 Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Million)
Table 13.165 Overall Elastomeric Closures Market: Conservative, Base and Optimistic Scenario, 2019, 2024 and 2030 (USD Billion)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook